02469nam 2200685z- 450 991055766540332120231214132837.0(CKB)5400000000044852(oapen)https://directory.doabooks.org/handle/20.500.12854/76275(EXLCZ)99540000000004485220202201d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierThe Immunology and Biology of Brain TumorsBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 electronic resource (88 p.)3-0365-0102-9 3-0365-0103-7 Immunotherapy has become a viable treatment modality for a variety of cancers (and referred to as Science Magazine’s “Breakthrough of the Year” in 2013, as well as ASCO’s “Advance of the Year” in both 2016 and 2017). This Special Issue is focused on the relevance of immunobiology in brain tumors, touching on elements of immune suppression, immune stimulation, and the immune microenvironment, with culminations in translational immunotherapy.Medicinebicsscvaccine therapyoncoantigentumor associate antigentumor angiogenesishigh-grade gliomapituitary neuroendocrine tumorsVEGFTregTAMPD-1PD-L1tumor microenvironment (TME)glioblastoma multiforme (GBM)GBM-associated macrophages (GAMs)exosomesoncomiR-21STAT3 inhibitorgliomadiffusion tensor imaginggeneralized q-ball imagingtreatment-related effectsmultiple resectionsadrenal insufficiencyAddison’s diseasebevacizumabcerebral radiation necrosiscraniopharyngiomainflammationcheckpoint inhibitorsInterleukin-6MedicineGraner Michaeledt1327016Graner MichaelothBOOK9910557665403321The Immunology and Biology of Brain Tumors3037797UNINA